Ara
Toplam kayıt 57, listelenen: 31-40
Impact of COVID-19 on urology practice: A global perspective and snapshot analysis
(MDPI, 2020)
The global impact of the 2019 novel coronavirus disease (COVID-19) pandemic on urology practice remains unknown. Self-selected urologists worldwide completed an online survey by the Societe Internationale d'Urologie (SIU). ...
Lasers in transurethral enucleation of the prostate-do we really need them
(Multidisciplinary Digital Publishing Institute, 2020)
The acronym EEP, coding for transurethral Endoscopic Enucleation of the Prostate, was introduced in 2016 by the European Association of Urology (EAU) guidelines panel on management of non-neurogenic male lower urinary tract ...
Classification and standardized reporting of percutaneous nephrolithotomy (PCNL): International alliance of urolithiasis (IAU) consensus statements
(2022)
Background: To reach a consensus in the classification and standardized reporting for the different types of PCNLs. Methods: The RAND/UCLA appropriateness methodology was used to reach a consensus. Thirty-two statements ...
Evaluation of patterns of presentation, practice, and outcomes of upper tract urothelial cancer: protocol for an observational, international, multicenter, cohort study by the clinical research office of the endourology society
(Jmir Publications, 2020)
Background: Available guidelines on the management of upper tract urothelial carcinoma (UTUC) are restricted due to the lack of strong evidence-based recommendations. Adequate, well-powered randomized trials are missing ...
Molecular biomarkers in the context of focal therapy for prostate cancer: Recommendations of a delphi consensus from the focal therapy society
(Edizioni Minerva Medica, 2022)
BACKGROUND: Focal therapy (FT) for prostate cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in ...
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: Current perspective and ongoing trials
(Springer, 2021)
Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there ...
Preservation of antegrade ejaculation after surgical relief of benign prostatic obstruction is a valid endpoint
(Springer, 2021)
Purpose To review the current data on retrograde ejaculation (RE) and ejaculatory dysfunction (EjD) after endoscopic and minimally invasive surgical treatment of benign prostatic obstruction (BPO) and, their perceived ...
Focal laser ablation as clinical treatment of prostate cancer: Report from a Delphi consensus project
(Springer Verlag, 2019)
Purpose: To define the role of focal laser ablation (FLA) as clinical treatment of prostate cancer (PCa) using the Delphi consensus method. Methods: A panel of international experts in the field of focal therapy (FT) in ...
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international delphi consensus
(Elsevier Science Inc, 2021)
Background: With the advancement of imaging technology, focal therapy (FT) has been gaining acceptance for the treatment of select patients with localized prostate cancer (CaP). We aim to provide details of a formal physician ...
Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences
(Sage Publications LTD, 2019)
Background: At present, it is not possible to predict the ablation zone volume following irreversible electroporation (IRE) for prostate cancer (PCa). This study aimed to determine the necessary electrical field threshold ...